New use of traditional Chinese medicinal material cordyceps cicadae

A technology of cinnabar japonica and uses, which is applied to the new use field of the traditional Chinese medicinal material cinnabar japonica, can solve problems such as side effects and poor effect of uric acid western medicine, and achieve the effect of obvious effect.

Inactive Publication Date: 2016-11-23
湖州新驰医药科技有限公司
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is no Chinese patent medicine for effective prevention or treatment of gout in the market, and western medicines for reducing uric acid are not effective and have side eff

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment example 1

[0028] Implementation Case 1 Preparation and application effect of cicadae powder

[0029] Take 2kg of cicada flowers and shell them, coarsely powder them to 100 mesh, then finely powder them to 300 mesh, and pack them in 2g / bag. The patient takes 2 bags a day, one in the morning and one in the evening. After 7 days of continuous taking, the symptoms of gout have improved. After 20 days of continuous use, the symptoms of gout are basically eliminated, and after one month of use, the symptoms are completely eliminated. During the period of taking, avoid alcohol, spicy food, seafood, eat less meat, drink more water, eat more vegetables, and exercise more.

Embodiment example 2

[0030] Implementation Case 2 Preparation and Application Effect of Jinchanhua Capsules

[0031] Take 1 kg of cicada flower powder, put it into capsules at 1 g / capsule, take 4 capsules a day, 2 capsules in the morning and evening, after taking it for 7 days, the symptoms of gout have improved, and after taking it for 20 days, the symptoms of gout are basically eliminated. Alcohol, spicy, seafood, eat less meat, drink more water, eat more vegetables, and exercise more. After taking it for one month, the symptoms are completely eliminated.

Embodiment example 3

[0032] Implementation Case 3 Preparation and application effect of Jinchanhua Tablet

[0033] Take 1 kg of cicada flower powder, press 1 g / tablet, the patient takes 4 tablets a day, 2 tablets in the morning and evening, after 7 days of continuous taking, the symptoms of gout are improved, and after 20 days of continuous taking, the symptoms of gout are basically eliminated. During the period of taking, avoid Alcohol, spicy, seafood, eat less meat, drink more water, eat more vegetables, and exercise more. After taking it for one month, the symptoms are completely eliminated.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to use of cordyceps cicadae in preparation of drugs for preventing or treating gout. According to the use, due to cordyceps cicada preparation products, a novel gout preventing or treating method is provided and is obvious in effect. The cordyceps cicadae have the functions of reducing blood and urine creatinine, increasing endogenous creatinine clearance rate, increasing the content of serum protein, reducing the discharge of urinary protein, and the like. Therefore, the cordyceps cicadae have definite treatment effect on early- and middle-stage chronic renal insufficiency patients. Confirmed by further researches: the cordyceps cicadae have relatively good treatment effect on renal tubulointerstitial lesions and can be used for protecting Na<+>-K<+>-ATPase of renal tubule cells, alleviating cytolysosome and cell lipid peroxidation injury, improving renal hemodynamics and alleviating endothelial cell injury and blood coagulation property.

Description

technical field [0001] The present invention relates to a new application of cicadas, especially the application of cicadas in medicines for preventing or treating gout. Background technique [0002] Gout is a crystal-associated arthropathy caused by the deposition of monosodium urate (MSU), which is directly related to hyperuricemia caused by purine metabolic disorders and / or decreased uric acid excretion, especially acute characteristic arthritis and Chronic tophi diseases mainly include acute onset arthritis, tophi formation, tophi chronic arthritis, urate nephropathy and uric acid urolithiasis. In severe cases, joint disability and renal insufficiency may occur. Gout is often accompanied by abdominal obesity, hyperlipidemia, hypertension, type 2 diabetes and cardiovascular disease. [0003] At present, there is no Chinese patent medicine for effective prevention or treatment of gout in the market, and western medicines for reducing uric acid are not effective and have s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/066A61P19/06A61K35/64
CPCA61K36/066A61K35/63A61K2236/331A61K2236/333A61K2300/00
Inventor 程绯
Owner 湖州新驰医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap